The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Shirley A. Bayer sits on this spectrum.
This scientist: 145 publications — 40th percentile
40% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Shirley A. Bayer sits on this spectrum.
This scientist: 69 D-Index — 73rd percentile
73% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Shirley A. Bayer is affiliated with Indiana University - Purdue University Indianapolis in the United States. Their research spans multiple fields including Medicine, Biochemistry, Genetics and Molecular Biology, and Neuroscience. The subfields of study associated with their work include Molecular Biology, Anesthesiology and Pain Medicine, Neurology, and Psychiatry and Mental Health.
The scientist has contributed to the study of several main topics, notably:
Among their recent scholarly contributions is the paper titled 14. Waveform utilization and outcomes of spinal cord stimulation in CRPS patients: a multicenter real-world observational study, published in 2025 in the journal Neuromodulation Technology at the Neural Interface. This study reflects their engagement in clinical and technological aspects of pain management.
The scientist has collaborated frequently with several coauthors including Pedro Moura Ferreira, Dandan Zhu, Rebecca Lim, Blerina Ahmetaj-Shala, and Matthew Hind.
Shirley A. Bayer's research outputs are primarily published in venues such as:
Through their work, they address complex biomedical and neurological issues with a focus on pain-related conditions and interventions. The integration of molecular biology with clinical treatments indicates a multidisciplinary approach to understanding and managing neurological disorders and associated symptoms.
Joseph Altman;Shirley A. Bayer
Shirley A. Bayer
S. A Bayer;J Altman;R. J Russo;Xin Zhang
Joseph Altman;Shirley A. Bayer
Shirley A. Bayer;James W. Yackel;Prem S. Puri
Joseph Altman;Shirley A. Bayer
S. A. Bayer
Joseph Altman;Robert L. Brunner;Shirley A. Bayer
Joseph Altman;Shirley A. Bayer;Clark Gedney
Joseph Altman;Shirley A. Bayer
Joseph Altman;Shirley A. Bayer
Shirley A. Bayer
Joseph Altman;Shirley A. Bayer
Shirley A. Bayer;Joseph Altman
S. A. Bayer
Joseph Altman;Shirley A. Bayer
Joseph Altman;Shirley A. Bayer
Shirley A. Bayer;Joseph Altman
Shirley A. Bayer;Joseph Altman
Joseph Altman;Shirley A. Bayer
If you think any of the details on this page are incorrect, let us know.
Washington State University
IBM (United States)
Micron (United States)
York University
University of Geneva
Lund University
National Center for Atmospheric Research
University of Lorraine
Sony (Japan)
Arizona State University
Virginia Tech
Indian Institute of Technology Delhi
National Research Council (CNR)
Yale University
Cornell University
University of Göttingen
